Reta is a novel investigational drug designed to target multiple hormone receptors involved in metabolism. Unlike older medications that focus on a single pathway, reta acts on three key receptors:

• GLP-1 (glucagon-like peptide-1)
• GIP (glucose-dependent insulinotropic polypeptide)
• Glucagon receptor

This triple-action mechanism is what makes it particularly exciting. Early studies suggest it may lead to significant weight loss and improved blood sugar control. Some trial participants experienced weight reductions that rival or exceed currently approved medications.